Skin Elements Ltd Q1 FY2026 Financial Report
Key points
- Secured $1.47M in capital funding through options exercise and placement
- Entered exclusive distribution agreement with Farmlands for ECO-Nurture
- Completed board renewal with new directors appointed
- Received $288K interim advance from Radium Capital for R&D rebate
- Net cash outflows from operating activities for the quarter were $874K
Full summary
Skin Elements Ltd (ASX: SKN) released its Quarterly Activity Report for Q1 FY2026, highlighting key achievements and financial details. The company secured $1.47M in capital funding through the exercise of unlisted options and a placement, raising $570K and $900K respectively. An exclusive distribution agreement was secured with Farmlands Co-Operative Society for ECO-Nurture, a horticultural bio-stimulant, with an initial order of 4,000 liters. The company also completed a board renewal, appointing new directors and removing existing ones. Additionally, Skin Elements received an interim advance of $288K from Radium Capital for its R&D rebate. Despite these achievements, the company reported net cash outflows from operating activities of $874K for the quarter.
Guidance
Net cash outflows from operating activities for the quarter were $874K
Outlook
Skin Elements expects to continue operations and meet business objectives with existing cash reserves, increased sales from Farmlands, and additional cash from the July equity placement.
Summary generated by a large language model. Please interpret with care.